Madrigal Pharmaceuticals Stock Statistic Functions Standard Deviation

MDGL Stock  USD 435.01  1.86  0.43%   
Madrigal Pharmaceuticals statistic functions tool provides the execution environment for running the Standard Deviation function and other technical functions against Madrigal Pharmaceuticals. Madrigal Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of statistic functions indicators. As with most other technical indicators, the Standard Deviation function function is designed to identify and follow existing trends. Madrigal Pharmaceuticals statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period and Deviations to execute this module.

Function
Time Period
Deviations
Execute Function
The output start index for this execution was nine with a total number of output elements of fifty-two. Madrigal Pharmaceuticals Standard Deviation measures the spread of Madrigal Pharmaceuticals time series from expected value (the mean).

Madrigal Pharmaceuticals Technical Analysis Modules

Most technical analysis of Madrigal Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Madrigal from various momentum indicators to cycle indicators. When you analyze Madrigal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Madrigal Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Madrigal Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Madrigal Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Madrigal Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Madrigal Pharmaceuticals's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Madrigal Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Madrigal Pharmaceuticals, we also check how macroeconomic factors affect Madrigal Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2025 2026 (projected)
Dividend Yield0.0082670.007348
Price To Sales Ratio13.6312.95
Hype
Prediction
LowEstimatedHigh
431.36434.08436.80
Details
Intrinsic
Valuation
LowRealHigh
391.51492.56495.28
Details
Naive
Forecast
LowNextHigh
409.49412.21414.93
Details
15 Analysts
Consensus
LowTargetHigh
607.49667.57741.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Madrigal Pharmaceuticals. Your research has to be compared to or analyzed against Madrigal Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Madrigal Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Madrigal Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Madrigal Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Madrigal Pharmaceuticals' short interest history, or implied volatility extrapolated from Madrigal Pharmaceuticals options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 90 shares
ESG Investing Idea
ESG Investing
Sold few shares
Corona Opportunity Idea
Corona Opportunity
Invested over 90 shares
When determining whether Madrigal Pharmaceuticals is a strong investment it is important to analyze Madrigal Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Madrigal Pharmaceuticals' future performance. For an informed investment choice regarding Madrigal Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. Expected growth trajectory for Madrigal significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Madrigal Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(12.91)
Revenue Per Share
42.72
Quarterly Revenue Growth
2.108
Return On Assets
(0.16)
Return On Equity
(0.42)
Investors evaluate Madrigal Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Madrigal Pharmaceuticals' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Madrigal Pharmaceuticals' market price to deviate significantly from intrinsic value.
Understanding that Madrigal Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Madrigal Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Madrigal Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.